Can latent toxoplasmosis lead to Alzheimer's disease?


  • Shameeran Salman Ismael Medical Laboratory Sciences Department, College of Health Sciences, University of Duhok, Iraq
  • Shaimaa Hamid Hasan Anesthesia Sciences Department, College of Health Sciences, University of Duhok, Iraq



Alzheimer, Toxoplasma gondii, latent toxoplasmosis


Bhushan I, Kour M, Kour G, Gupta S, Sharma S, Yadav A. Alzheimer’s disease: Causes & treatment – A review. Annals of Biotechnology. 2018; 1(1): 1002.

Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. The New England Journal of Medicine. 2003; 348(14), 1356–1364.

Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline. Journal of Alzheimer’s disease: JAD. 2015; 48(4), 1095–1107.

Querfurth HW, LaFerla FM. Alzheimer’s disease. The New England Journal of Medicine. 2010; 362(4), 329–344.

Ribas MZ, Paticcié GF, Noleto FM, et al. Impact of dysexecutive syndrome in quality of life in Alzheimer disease: What we know now and where we are headed. Ageing Res Rev. 2023; 86:101866.

Suzuki Y, Sa Q, Ochiai E, Mullins J, Yolken R, Halonen SK. Cerebral Toxoplasmosis: Pathogenesis, Host Resistance and Behavioural

Consequences. Toxoplasma gondii (Second Edition), 2013; 755–796.

Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine? The American Journal of the Medical Sciences,. 2009; 338(2), 120–122.

Kaushik M, Lamberton PH, Webster JP. The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Hormones and Behavior. 2012; 62(3), 191–201.

Jung BK, Pyo KH, Shin KY, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer’s disease. PLoS One. 2012;7(3):e33312.

Nayeri T, Sarvi S, Sharif M, Daryani A. Toxoplasma gondii: A possible etiologic agent for Alzheimer’s disease. Heliyon. 2021;7(6):e07151.

Bouscaren N, Pilleron S, Mbelesso P, et al. Prevalence of toxoplasmosis and its association with dementia in older adults in Central Africa: a result from the EPIDEMCA programme. Trop Med Int Health. 2018; 23(12):1304–1313.

Yang HY, Chien WC, Chung CH, et al. Risk of dementia in patients with toxoplasmosis: a nationwide, population-based cohort study in Taiwan. Parasit Vectors. 2021; 14(1):435.

Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009; 16(2):122–133.

McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma gondii infection and behaviour - location, location, location?. The Journal of Experimental Biology. 2013; 216(Pt 1), 113–119.

Perry CE, Gale SD, Erickson L, et al. Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease. Alzheimer Dis Assoc Disord. 2016;30(2):123–126.

Mahami-Oskouei M, Hamidi F, Talebi M, et al. Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?. Parasitol Res. 2016; 115(8):3169–3174.




How to Cite

Salman Ismael , S. ., & Hamid Hasan, S. . (2023). Can latent toxoplasmosis lead to Alzheimer’s disease?. Journal of Contemporary Medical Sciences, 9(5).



Letter to editor